Efavirenz Versus Rilpivirine on Vascular Function, Inflammation, and Oxidative Stress

This study has been completed.
Sponsor:
Collaborator:
Janssen Services, LLC
Information provided by (Responsible Party):
Samir K Gupta, MD, MS, Indiana University
ClinicalTrials.gov Identifier:
NCT01585038
First received: April 23, 2012
Last updated: March 23, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)